Inactief instrument

Andere talen Natco Pharma Ltd. NSE India S.E.

Aandelen

INE987B01018

slotkoers NSE India S.E. Andere beurzen
- ^INR	-

28/05	INDIA STOCKS - Metaal- en farmaceutische aandelen stuwen Indiase benchmarks omhoog	RE
28/05	Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher	28/05
Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024	28/05
NATCO Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	27/05
NATCO Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27/05
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	08/05
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	08/05
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	08/05
Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	09/04
NATCO Pharma Limited Announces Board Appointments	27/03
INDIA STOCKS-Indian shares erase early gains, weighed down by IT stocks	19/02
NATCO Pharma Limited Revises Earnings Guidance for the Fiscal Year 2024	15/02
Transcript : NATCO Pharma Limited, Q3 2024 Earnings Call, Feb 15, 2024	15/02
Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024	14/02
NATCO Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Floods Disrupt Operations of Natco Pharma's Plant in Tamil Nadu, India	07/12
Transcript : NATCO Pharma Limited, Q2 2024 Earnings Call, Nov 15, 2023	15/11
Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend	14/11
NATCO Pharma Limited Declares Second Interim Dividend for the Financial Year 2023-24, Payable on 1 December, 2023	14/11
NATCO Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11
US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India	02/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Natco Pharma Ltd. NSE India S.E.

Aandelen

INE987B01018

Andere talen

Filters